Drug Shortage Report for 5% DEXTROSE INJECTION, USP

Last updated on 2024-12-02 History
Report ID 229848
Drug Identification Number 00060348
Brand name 5% DEXTROSE INJECTION, USP
Common or Proper name 5% DEXTROSE INJECTION, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 5G
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ML - JB0040
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-06-07
Actual start date 2024-06-07
Estimated end date 2024-11-30
Actual end date 2024-11-30
Shortage status Resolved
Updated date 2024-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-06-06 English Compare
v2 2024-06-06 French Compare
v3 2024-06-08 English Compare
v4 2024-06-19 English Compare
v5 2024-06-19 French Compare
v6 2024-07-19 English Compare
v7 2024-07-19 French Compare
v8 2024-07-23 English Compare
v9 2024-07-23 French Compare
v10 2024-08-06 English Compare
v11 2024-08-06 French Compare
v12 2024-09-03 English Compare
v13 2024-09-03 French Compare
v14 2024-10-11 English Compare
v15 2024-10-11 French Compare
v16 2024-10-31 English Compare
v17 2024-10-31 French Compare
v18 2024-12-02 English Compare
v19 2024-12-02 French Compare
v20 2024-12-02 English Compare

Showing 1 to 20 of 21